How One Woman Champions Her Vitiligo Care – and Advocates for Other Patients
This article is sponsored by Incyte. Lisa was compensated for her time participating in the interview. For Lisa, life with ...
Hosted on MSN2d
Targeted Oral Drug Plus UV Therapy May Help in Extensive Vitiligo
Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...
pharmaphorum3d
FDA sets April date for verdict on Incyte's vitiligo drug
If approved, Opzelura would provide an alternative to steroid drugs currently used to treat vitiligo, a chronic autoimmune disease that causes depigmentation of skin and affects around 1.5 million ...
EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…
EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA ...
pharmaphorum1y
Incyte’s oral vitiligo drug heading for phase 3
Last year, Incyte became the first pharma company to get approval for a drug that can re-pigment the skin in vitiligo – topical JAK1/JAK2 inhibitor Opzelura (ruxolitinib) – for patients whose ...
Notable Insider Move: PABLO CAGNONI Takes Part In Options Exercise At Incyte, Resulting In $0
What Happened: The latest Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission uncovered CAGNONI, ...
Healio25d
Paramedical tattoos lead Healio’s 2024 vitiligo coverage
Read more. Safety data show ruxolitinib cream well tolerated in atopic dermatitis, vitiligo at 1 year Safety data for ruxolitinib cream (Opzelura, Incyte), a Janus kinase inhibitor, in the first ...
Insider Decision Unfolding At Incyte: Matteo Trotta Exercises Options, Resulting In $0
What Happened: A notable Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission revealed that Trotta, EVP at Incyte, exercised stock options for 0 shares of INCY, resulting in a ...
Yahoo Finance9d
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
A supplemental NDA has been submitted for Incyte’s Opzelura cream ... hidradenitis suppurativa, vitiligo and prugrigo nodularis. The data for the Phase III hidradenitis suppurativa trial ...